SABS - SAB Biotherapeutics enters into securities purchase agreement
2023-10-02 08:17:26 ET
More on SAB Biotherapeutics
- SAB Biotherapeutics GAAP EPS of -$0.14
- Seeking Alpha’s Quant Rating on SAB Biotherapeutics
- Historical earnings data for SAB Biotherapeutics
- Financial information for SAB Biotherapeutics
For further details see:
SAB Biotherapeutics enters into securities purchase agreement